CSPG4 and ovarian cancer: Finally, bulk T cells were equipped with a CSPG4-specific CAR, and antigen-specific targetability of decitabine-treated SKOV-3 ovarian cancer cells by CSPG4-specific CAR-T cells was demonstrated.